| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/05/2001 | US20010006635 Decreasing localized inflammatory responses in a tissue of a patient by administering to said patient heparinase enzyme in an effective amount sufficient to decrease said localized inflammatory response |
| 07/05/2001 | DE19963178A1 Substituierte Indol-Mannichbasen Substituted indole Mannich bases |
| 07/05/2001 | DE19962924A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 07/05/2001 | CA2699568A1 Azaindoles |
| 07/05/2001 | CA2396693A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2396516A1 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/05/2001 | CA2396502A1 Substituted pyrrole mannich bases |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395996A1 Neuroprotective drug |
| 07/05/2001 | CA2395950A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395575A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | CA2395561A1 Benzophenone glycopyranosides, preparation and therapeutic use |
| 07/05/2001 | CA2395557A1 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use |
| 07/05/2001 | CA2395548A1 Imidazo 1,3,5 triazinones and the use thereof |
| 07/05/2001 | CA2395544A1 Method of achieving persistent transgene expression |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395418A1 Isoxazolo pyrimidinones and the use thereof |
| 07/05/2001 | CA2395410A1 Triazolotriazinones and the use thereof |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2395275A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | CA2395249A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 07/05/2001 | CA2395179A1 Nitrile derivatives as cathepsin k inhibitors |
| 07/05/2001 | CA2395173A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | CA2394944A1 Combinations of a receptor tyrosine kinase inhibitor with an organic compound capable of binding to .alpha.1-acidic glycoprotein |
| 07/05/2001 | CA2394727A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | CA2394174A1 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | CA2394098A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | CA2394097A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | CA2392866A1 Substituted indole mannich bases |
| 07/04/2001 | EP1113014A1 Linear or cyclic ureas, a process for their preparation and pharmaceutical compositions containing them |
| 07/04/2001 | EP1113011A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 07/04/2001 | EP1113007A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 07/04/2001 | EP1112381A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/04/2001 | EP1112368A1 Use of protein kinase kiaa0551 as pharmaceutical |
| 07/04/2001 | EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 07/04/2001 | EP1112275A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 07/04/2001 | EP1112271A1 Ergoline amine derivatives with blood pressure lowering effect |
| 07/04/2001 | EP1112266A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 07/04/2001 | EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112090A2 Method of stimulating prosaposin receptor activity |
| 07/04/2001 | EP1112089A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use |
| 07/04/2001 | EP1112088A1 Method for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
| 07/04/2001 | EP1112085A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 07/04/2001 | EP1112083A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | EP1112005A1 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid |
| 07/04/2001 | EP0850236B1 Piperazino derivatives as neurokinin antagonists |
| 07/04/2001 | EP0783308B1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 07/04/2001 | CN1302301A Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidine sas inhibitors of cellular proliferation |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302208A Smilagenin and anzurogenin-D for curing Alzheimer's disease |
| 07/04/2001 | CN1302206A Therapeutic uses of quinoline derivatives |
| 07/04/2001 | CN1302205A Use of benzofuroxan derivatives in treating angina pectoris |
| 07/04/2001 | CN1302204A Novel fatty analogues for treatment of diabetes |
| 07/04/2001 | CN1301699A New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 07/04/2001 | CN1301558A Compound ginkgo health product and preparing method |
| 07/04/2001 | CN1301554A Medicine for curing coronary heart disease |
| 07/04/2001 | CN1301549A Method for producing chinese medicine for curing cardio-cerebrol vascular disease |
| 07/04/2001 | CN1301545A Compound depressor |
| 07/04/2001 | CN1301539A Hemorrhoid medicine |
| 07/04/2001 | CN1068001C Heterocycle substituted propenoid acid derivatives as NMDA antagonists |
| 07/04/2001 | CN1068000C Apolioprotein -B synthesis inhibitors |
| 07/04/2001 | CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds |
| 07/04/2001 | CN1067987C 取代的吲哚衍生物 Substituted indole derivatives |
| 07/04/2001 | CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors |
| 07/04/2001 | CN1067880C Pingyasan for hypertension |
| 07/03/2001 | US6255512 High energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions, andpharmaceutical agents |
| 07/03/2001 | US6255471 CRFG-1b, a target and marker for chronic renal failure |
| 07/03/2001 | US6255468 MPROT12 polynucleotides and methods thereof |
| 07/03/2001 | US6255453 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/03/2001 | US6255330 Heterocyclically substituted phenylglycinolamides |
| 07/03/2001 | US6255327 Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions |
| 07/03/2001 | US6255319 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands |
| 07/03/2001 | US6255306 4-indole derivatives as serotonin agonists and antagonists |
| 07/03/2001 | US6255298 Using an aromatic amide compound |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient |
| 07/03/2001 | CA2107466C Low density microspheres and their use as contrast agents for computed tomography |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/29/2001 | CA2328781A1 Novel antibacterial and prokinetic macrolides |
| 06/28/2001 | WO2001046455A2 Survivin promotion of angiogenesis |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046415A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | WO2001046397A2 Human kinases |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046263A1 Novel compounds |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046218A2 Fragments of pf4 and pharmaceutical compositions containing the same |
| 06/28/2001 | WO2001046206A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046205A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |